Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.

Effects of serelaxin in patients with acute heart failure / Metra, M.; Teerlink, J. R.; Cotter, G.; Davison, B. A.; Felker, G. M.; Filippatos, G.; Greenberg, B. H.; Pang, P. S.; Ponikowski, P.; Voors, A. A.; Adams, K. F.; Anker, S. D.; Arias-Mendoza, A.; Avendano, P.; Bacal, F.; Bohm, M.; Bortman, G.; Cleland, J. G. F.; Cohen-Solal, A.; Crespo-Leiro, M. G.; Dorobantu, M.; Echeverria, L. E.; Ferrari, R.; Goland, S.; Goncalvesova, E.; Goudev, A.; Kober, L.; Lema-Osores, J.; Levy, P. D.; Mcdonald, K.; Manga, P.; Merkely, B.; Mueller, C.; Pieske, B.; Silva-Cardoso, J.; Spinar, J.; Squire, I.; Stepinska, J.; Van Mieghem, W.; Von Lewinski, D.; Wikstrom, G.; Yilmaz, M. B.; Hagner, N.; Holbro, T.; Hua, T. A.; Sabarwal, S. V.; Severin, T.; Szecsody, P.; Gimpelewicz, C.. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - 381:8(2019), pp. 716-726. [10.1056/NEJMoa1801291]

Effects of serelaxin in patients with acute heart failure

Metra M.;
2019-01-01

Abstract

Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that contributes to cardiovascular and renal adaptations during pregnancy. Previous studies have suggested that treatment with serelaxin may result in relief of symptoms and in better outcomes in patients with acute heart failure.
2019
Acute Disease
Aged
Blood Pressure
Cardiovascular Diseases
Disease Progression
Double-Blind Method
Female
Heart Failure
Hospitalization
Humans
Incidence
Infusions
Intravenous
Male
Recombinant Proteins
Relaxin
Treatment Failure
Vasodilator Agents
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/194016
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 220
  • ???jsp.display-item.citation.isi??? 205
social impact